Abstract:Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role and mechanism of human bone marrow mesenchymal stem cells (MSCs) in Kaposi’s Sarcoma (KS). Specifically, the researchers hope to verify the following hypotheses through experiments: 1. **The influence of MSCs on tumor growth**: Different from the view in previous studies that MSCs may promote tumor growth, this study aims to explore whether MSCs have the ability to inhibit the growth of KS tumors. The researchers observed through in - vivo experiments whether intravenously injected human MSCs could migrate to the KS tumor site and evaluated their influence on tumor growth. 2. **The mechanism by which MSCs inhibit tumor growth**: The researchers further explored the specific mechanism by which MSCs inhibit the growth of KS tumors, especially how MSCs affect the signal pathways within tumor cells. They focused on whether MSCs inhibit the activation of Akt protein kinase through direct cell - to - cell contact and whether this inhibitory effect depends on the expression of E - cadherin. 3. **Whether the anti - tumor effect of MSCs is specific**: The study also explored the influence of MSCs on other types of cells (such as primary endothelial cells and cardiomyocytes) and different tumor cell lines (such as prostate cancer cells and breast cancer cells) to determine whether its anti - tumor effect is specific to KS cells. In summary, the main objective of this paper is to reveal the potential anti - tumor role of MSCs in KS tumors and its specific mechanism, thereby providing a scientific basis for the development of new treatment strategies.

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma